Heme synthesis is regulated in a highly tissue-specific manner. In particular, erythroid heme synthesis is regulated either by the erythroid-specific isozymes, or by upregulation of the erythroid-specific delta-aminolevulinate (ALA) synthase (ALAS2) by heme, the end-product of the heme biosynthetic pathway, while hepatic heme synthesis is downregulated by heme at the level of the non-specific delta-aminolevulinate (ALA) synthase (ALAS1).
The specific aim of this study is to define the nature of the erythroid- specific control of heme synthesis and the role of heme in gene expression in erythroid cells. The focus will be placed on the role of NF-E2, the erythroid transcription factor, on erythroid gene expression, and the erythroid heme pathway gene expression, especially that of ALAS2, on erythroid differentiation. The investigators plan to examine the regulation of NF-E2 activity in erythroid differentiation and the regulation of the human ALAS (hALAS2) gene expression. These studies will hopefully clarify the role of ALAS2 and transcription factors such as NF-E2 and Bach1 in erythroid differentiation, and shed light on the distinct aspects of erythroid heme synthesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK032890-18
Application #
6497875
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Badman, David G
Project Start
1983-08-01
Project End
2004-01-31
Budget Start
2002-02-01
Budget End
2004-01-31
Support Year
18
Fiscal Year
2002
Total Cost
$240,926
Indirect Cost
Name
Rockefeller University
Department
Microbiology/Immun/Virology
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Furuyama, Kazumichi; Harigae, Hideo; Heller, Tom et al. (2006) Arg452 substitution of the erythroid-specific 5-aminolaevulinate synthase, a hot spot mutation in X-linked sideroblastic anaemia, does not itself affect enzyme activity. Eur J Haematol 76:33-41
Akagi, Reiko; Inoue, Rikako; Muranaka, Shikibu et al. (2006) Dual gene defects involving delta-aminolaevulinate dehydratase and coproporphyrinogen oxidase in a porphyria patient. Br J Haematol 132:237-43
Akagi, Reiko; Kato, Noriko; Inoue, Rikako et al. (2006) delta-Aminolevulinate dehydratase (ALAD) porphyria: the first case in North America with two novel ALAD mutations. Mol Genet Metab 87:329-36
Sassa, Shigeru (2004) Why heme needs to be degraded to iron, biliverdin IXalpha, and carbon monoxide? Antioxid Redox Signal 6:819-24
Takahashi, T; Morita, K; Akagi, R et al. (2004) Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr Med Chem 11:1545-61
Doss, M O; Stauch, T; Gross, U et al. (2004) The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany. J Inherit Metab Dis 27:529-36
Watanabe, S; Akagi, R; Mori, M et al. (2004) Marked developmental changes in heme oxygenase-1 (HO-1) expression in the mouse placenta: correlation between HO-1 expression and placental development. Placenta 25:387-95
Kondo, Masao; Yano, Yuzo; Shirataka, Masuo et al. (2004) Porphyrias in Japan: compilation of all cases reported through 2002. Int J Hematol 79:448-56
Quigley, John G; Yang, Zhantao; Worthington, Mark T et al. (2004) Identification of a human heme exporter that is essential for erythropoiesis. Cell 118:757-66
Maeshima, Kyoichiro; Takahashi, Toru; Nakahira, Kiichi et al. (2004) A protective role of interleukin 11 on hepatic injury in acute endotoxemia. Shock 21:134-8

Showing the most recent 10 out of 98 publications